In a letter sent to one of the largest investors in America’s Big Three PBMs, APCI urged Vanguard, Inc., to use its influence to curb abusive PBM practices that increase prescription drug prices for patients.

Read More...

APCI and Transparency-Rx Unite in Congressional Advocacy for Critical PBM Reforms

Organizations to Underscore Need for Legislation that De-links Major PBM Profits from Drug Prices

APCI to Feds: Stop Further Healthcare Vertical Integration in Optum-Amedisys Deal

Study: PBMs setting wildly variable prescription prices for patients at the counter

APCI Urges Federal Agencies to Halt Further Integration of Insurers, PBMs

Comments call for DOJ, FTC investigation of PBM, insurer practices

APCI Calls on Major Institutional Investor to Demand PBM Changes

Categories